Key indicators: single-crystal X-ray study; T = 100 K; mean (C-C) = 0.003 Å; R factor = 0.049; wR factor = 0.128; data-to-parameter ratio = 24.8.
In the title compound [systematic name: (tert-butyldimethylsilyl)methanetriyl tris(4-methylbenzenesulfonate)], C 32 H 44 -O 10 S 3 Si, the central C atom and the Si IV center are in a tetrahedral configuration. The interplanar angles between pairs of the three benzene rings of the 4-methylphenylsulfonyl units are 41.15 (10), 18.11 (10) and 44.09 (10) . C-HÁ Á Á interactions are observed in the crystal structure. Molecules are linked into screw chains along the b axis by weak C-HÁ Á ÁO interactions. Weak intramolecular C-HÁ Á ÁO hydrogen bonds are also present.
Related literature
For bond-length data, see: Allen et al. (1987) . For background and applications of radioimmuno imaging, radioimmuno therapy and hypoxia markers, see, for example: Abdel-Jalil et al. Table 1 Hydrogen-bond geometry (Å , ) . 
Cg1 is the centroid of the C19-C24 ring.
Data collection: APEX2 (Bruker, 2005 ); cell refinement: APEX2; data reduction: SAINT (Bruker, 2005 ); program(s) used to solve structure: SHELXTL (Sheldrick, 2008 ); program(s) used to refine structure: SHELXTL; molecular graphics: SHELXTL; software used to prepare material for publication: SHELXTL and PLATON (Spek, 2003) .
O-(tert-Butyldimethylsilyl)tris(O-4-methylphenylsulfonyl)pentaerythritol
S.-X. Li, H.-M. Li, Z.-L. Lu, H.-K. Fun and S. Chantrapromma Comment Radio-immuno-imaging (RII) and radio-immuno-therapy (RIT) rely on the ability of a bifunctional molecule with a radioactive unit combined with a receptor-specific substrate such as 2-nitroimidazole unit which can act as a hypoxia marker (Abdel-Jalil et al., 2006; Monge et al., 2001; Nagasawa et al., 2006) . This approach allows radiopharmaceuticals to be delivered specifically to malignant tissue while minimizing the risk of unspecific irradiation of sane tissue. As part of our research on the synthesis of new potential hypoxia markers, we report herein the synthesis and crystal structure of the O-
In the title molecule ( The crystal packing of (I) in Fig. 2 shows that the molecules are linked into screw chains along the b axis by weak C17-H17C···O3 (symmetry code: 1 -x, 1/2 + y, 3/2 -z) and C25-H25B···O8 (symmetry code:-x, 1/2 + y, 3/2 -z) interactions (Table 1 ). The crystal is stabilized by weak C-H···O intra-and intermolecular interactions (Table 1) and further stabilized by C-H···π interactions (Table 1) ; Cg1 is the centroid of C19-C24 ring.
Experimental
The title compound was synthesized by disolving the 2,2-hydroxymethyl-2-(tert-butyldimethylsilyloxymethyl)-propan-1,3-diol (1.05 g, 4.0 mmol) in dry pyridine (40 ml) and tosyl chloride (3.05 g, 16.0 mmol) was then added. The reaction mixture was stirred for 24 h at room temperature, after which it was poured into ice-water (250 ml) and extracted with CH 2 Cl 2 (250 ml). The organic layer was washed with water (250 ml), dried with MgSO 4 and concentrated. The solid residue was purified by recrystalization with warm ethanol to afford the title compound as a white solid 2.27 g (yield: 80%). Colourless single crystals of the title compound suitable for x-ray structure determination were recrystallized from ethanol by slow evaporation of the solvent at room temperature [m.p. 371 K].
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Refinement
All H atoms were placed in calculated positions, with C-H = 0.93 Å, U iso = 1.2U eq (C) for aromatic, C-H = 0.97 Å, U iso = 1.2U eq (C) for CH 2 and C-H = 0.96 Å, U iso = 1.5U eq (C) for CH 3 atoms. A rotating group model was used for the methyl groups.
Figures Fig. 1 . The asymmetric unit of (I), showing 50% probability displacement ellipsoids and the atomic numbering. 
Special details
Experimental. The low-temparture data was collected with the Oxford Cryosystem Cobra low-temperature attachment. 
